Dexmedetomidine added to an opioid-based analgesic regimen for the prevention of postoperative nausea and vomiting in highly susceptible patients: A randomised controlled trial.

MLA

Song, Young, et al. “Dexmedetomidine Added to an Opioid-Based Analgesic Regimen for the Prevention of Postoperative Nausea and Vomiting in Highly Susceptible Patients: A Randomised Controlled Trial.” European Journal of Anaesthesiology, vol. 33, no. 2, Feb. 2016, pp. 75–83. EBSCOhost, https://doi.org/10.1097/EJA.0000000000000327.

APA

Song, Y., Shim, J.-K., Song, J.-W., Kim, E.-K., & Kwak, Y.-L. (2016). Dexmedetomidine added to an opioid-based analgesic regimen for the prevention of postoperative nausea and vomiting in highly susceptible patients: A randomised controlled trial. European Journal of Anaesthesiology, 33(2), 75–83. https://doi.org/10.1097/EJA.0000000000000327

Chicago

Song, Young, Jae-Kwang Shim, Jong-Wook Song, Eui-Kyung Kim, and Young-Lan Kwak. 2016. “Dexmedetomidine Added to an Opioid-Based Analgesic Regimen for the Prevention of Postoperative Nausea and Vomiting in Highly Susceptible Patients: A Randomised Controlled Trial.” European Journal of Anaesthesiology 33 (2): 75–83. doi:10.1097/EJA.0000000000000327.